Meng Fanwei, Modo Michel, Badylak Stephen F
McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15203, USA.
Regen Med. 2014 May;9(3):367-83. doi: 10.2217/rme.14.9.
Injury to the CNS typically results in significant morbidity and endogenous repair mechanisms are limited in their ability to restore fully functional CNS tissue. Biologic scaffolds composed of individual purified components have been shown to facilitate functional tissue reconstruction following CNS injury. Extracellular matrix scaffolds derived from mammalian tissues retain a number of bioactive molecules and their ability for CNS repair has recently been recognized. In addition, novel biomaterials for dural mater repairs are of clinical interest as the dura provides barrier function and maintains homeostasis to CNS. The present article describes the application of regenerative medicine principles to the CNS tissues and dural mater repair. While many approaches have been exploring the use of cells and/or therapeutic molecules, the strategies described herein focus upon the use of extracellular matrix scaffolds derived from mammalian tissues that are free of cells and exogenous factors.
中枢神经系统(CNS)损伤通常会导致严重的发病率,并且内源性修复机制在完全恢复功能性CNS组织的能力方面有限。由单个纯化成分组成的生物支架已被证明可促进CNS损伤后功能性组织的重建。源自哺乳动物组织的细胞外基质支架保留了许多生物活性分子,并且它们对CNS修复的能力最近已得到认可。此外,用于硬脑膜修复的新型生物材料具有临床意义,因为硬脑膜为CNS提供屏障功能并维持内环境稳定。本文描述了再生医学原理在CNS组织和硬脑膜修复中的应用。虽然许多方法一直在探索使用细胞和/或治疗分子,但本文所述的策略侧重于使用源自哺乳动物组织的无细胞和外源性因素的细胞外基质支架。